Intrinsic Value of S&P & Nasdaq Contact Us

BrightSpring Health Services, Inc. Tangible Equity Unit BTSGU NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
46/100
1/6 Pass
SharesGrow Intrinsic Value
$83.82
-45.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) trades at a trailing P/E of 49.0, forward P/E of 98.9. Trailing earnings yield is 2.04%, forward earnings yield 1.01%. PEG 1.26. Graham Number is $14.04.

Criteria proven by this page:

  • VALUE (56/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • PEG Ratio 1.26 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield 2.04% — below bond yields — investors are paying a premium for expected growth rather than current earnings.

Overall SharesGrow Score: 45/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
46/100
SG Score
View full scorecard →
~
VALUE
56/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
25/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
41/100
→ Income
GROWTH
90/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — BTSGU

Valuation Multiples
P/E (TTM)49.0
Forward P/E98.9
PEG Ratio1.26
Forward PEG1.26
P/B Ratio4.98
P/S Ratio0.69
EV/EBITDA25.4
Per Share Data
EPS (TTM)$0.94
Forward EPS (Est.)$1.55
Book Value / Share$9.31
Revenue / Share$63.74
FCF / Share$2.42
Yields & Fair Value
Earnings Yield2.04%
Forward Earnings Yield1.01%
Dividend Yield0.00%
Graham Number$14.04
SharesGrow IV$83.82 (-45.5%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2018 -247.1 0.00 0.00 0.74 -
2019 -26.0 -0.03 2.87 0.42 -
2020 90.5 -0.70 2.67 0.34 -
2021 37.8 0.27 2.43 0.28 -
2022 -34.9 0.17 2.49 0.24 -
2023 -12.2 -0.06 3.22 0.21 -
2024 -182.0 2.03 1.99 0.29 -
2025 39.8 -0.04 4.05 0.59 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2018 $-1.57 $2.54B $-7.62M -0.3%
2019 $-10.26 $4.53B $-72.38M -1.6%
2020 $2.78 $5.58B $20.81M 0.4%
2021 $0.29 $6.7B $49.8M 0.7%
2022 $-0.31 $7.72B $-53.91M -0.7%
2023 $-0.90 $8.83B $-154.6M -1.8%
2024 $-0.09 $11.27B $-18.06M -0.2%
2025 $0.87 $12.91B $190.67M 1.5%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $1.55 $1.45 – $1.60 $14.84B $14.72B – $14.99B 1
2027 $1.95 $1.82 – $2.01 $16.7B $15.17B – $17.25B 1
2028 $2.60 $2.42 – $2.67 $19.2B $18.19B – $19.62B 1
2029 $3.61 $3.36 – $3.71 $22.98B $21.78B – $23.49B 1
2030 $5.24 $4.88 – $5.39 $27.89B $26.42B – $28.49B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message